The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Abstract
An understanding of the events that occur during GH receptor (GHR) signaling has facilitated the development of a GHR antagonist (pegvisomant) for use in humans. This molecule has been designed to compete with native GH for the GHR and to prevent its proper or functional dimerization-a process that is critical for GH signal transduction and IGF-I synthesis and secretion. Clinical trials in patients with acromegaly show GHR blockade to be an exciting new mode of therapy for this condition, and pegvisomant may have a therapeutic role in diseases, such as diabetes and malignancy, in which abnormalities of the GH/IGF-I axis have been observed. This review charts the discovery and development of GHR antagonists and details the experience gained in patients with acromegaly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Growth hormone receptor and serum binding protein: purification, cloning and expression
Leung, D. W., Spencer, S. A., Cachianes, G., Hammonds, R. G., Collins, C., Henzel, W. J., Barnard, R., Waters, M. J., & Wood, W. I. (1987) · Nature · doi:10.1038/330537a0 · Cited by 1,522
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis
Cunningham, B. C., & Wells, J. A. (1989) · Science · doi:10.1126/science.2471267 · Cited by 1,367
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Reichlin, S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312153092406 · Cited by 1,044
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., & Carter-Su, C. (1993) · Cell · doi:10.1016/0092-8674(93)90415-m · Cited by 974
Sjögren, K., Liu, J.-L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., LeRoith, D., Törnell, J., Isaksson, O. G. P., Jansson, J.-O., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7088 · Cited by 938
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Self-citationCunningham, B. C., Ultsch, M., de Vos, A. M., Mulkerrin, M. G., Clauser, K. R., & Wells, J. A. (1991) · Science · doi:10.1126/science.1948064 · Cited by 874
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L., Reed, M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T. E., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13215 · Cited by 802
Self-citationThe pituitary-specific transcription factor GHF-1 is a homeobox-containing protein
Bodner, M., Castriilo, J.-L., Theill, L. E., Deerinck, T., Ellisman, M., & Karin, M. (1988) · Cell · doi:10.1016/0092-8674(88)90037-2 · Cited by 757
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
The Prolactin/Growth Hormone Receptor Family
KELLY, P. A., DJIANE, J., POSTEL-VINAY, M.-C., & EDERY, M. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-3-235 · Cited by 727
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, A. J., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06844-1 · Cited by 645
Self-citationHaemopoietic receptors and helical cytokines
Bazan, J. F. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90139-z · Cited by 638
Rational Design of Potent Antagonists to the Human Growth Hormone Receptor
Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V., & Wells, J. A. (1992) · Science · doi:10.1126/science.256.5064.1677 · Cited by 631
Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice 1
Coschigano, K. T., Clemmons, D., Bellush, L. L., & Kopchick, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.7.7586 · Cited by 611
Self-citationGodowski, P. J., Leung, D. W., Meacham, L. R., Galgani, J. P., Hellmiss, R., Keret, R., Rotwein, P. S., Parks, J. S., Laron, Z., & Wood, W. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8083 · Cited by 604
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
Swearingen, B., Barker, F. G., Katznelson, L., Biller, B. M. K., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P. M., & Zervas, N. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5222 · Cited by 586
Mechanism of the Stimulatory Effect of Growth Hormone on Longitudinal Bone Growth*
ISAKSSON, O. G. P., LINDAHL, A., NILSSON, A., & ISGAARD, J. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-426 · Cited by 580
Determinants of clinical outcome and survival in acromegaly
Rajasoorya, C., Holdaway, I. M., Wrightson, P., Scott, D. J., & Ibbertson, H. K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03789.x · Cited by 565
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
Wright, A. D., Hill, D. M., Lowy, C., & Fraser, T. R. (1970) · PubMed · Cited by 529
Wilks, A. F., Harpur, A. G., Kurban, R. R., Ralph, S. J., Zürcher, G., & Ziemiecki, A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2057 · Cited by 528
BENGTSSON, B., EDÉN, S., ERNEST, I., ODÉN, A., & SJÖGREN, B. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15881.x · Cited by 528
A dual effector theory of growth-hormone action
Green, H., Morikawa, M., & Mxon, T. (1985) · Differentiation · doi:10.1111/j.1432-0436.1985.tb00316.x · Cited by 514
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475
EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION
ALEXANDER, L., APPLETON, D., HALL, R., ROSS, W. M., & WILKINSON, R. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb03135.x · Cited by 466
An audit of outcome of treatment in acromegaly
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068816 · Cited by 466
Three-dimensional structure of a genetically engineered variant of porcine growth hormone.
Abdel-Meguid, S. S., Shieh, H. S., Smith, W. W., Dayringer, H. E., Violand, B. N., & Bentle, L. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6434 · Cited by 458
NABARRO, J. D. N. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00805.x · Cited by 442
Melmed, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221405 · Cited by 438
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., & Traish, D. (1992) · BMJ · doi:10.1136/bmj.304.6838.1343 · Cited by 413
Molecular pharmacology of somatostatin receptor subtypes
Patel, Y. C. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03350317 · Cited by 409
Structure and Evolution of the Growth Hormone Gene Family
MILLER, W. L., & EBERHARDT, N. L. (1983) · Endocrine Reviews · doi:10.1210/edrv-4-2-97 · Cited by 400
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly
Swearingen, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3419 · Cited by 400
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995
Lamberts, S. W. J., Uitterlinden, P., Verschoor, L., van Dongen, K. J., & del Pozo, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132504 · Cited by 397
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M. (1997) · Science · doi:10.1126/science.276.5319.1706 · Cited by 393
Self-citationNiall, H. D., Hogan, M. L., Sauer, R., Rosenblum, I. Y., & Greenwood, F. C. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.866 · Cited by 372
Abosch, A., Tyrrell, J. B., Lamborn, K. R., Hannegan, L. T., Applebury, C. B., & Wilson, C. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3411 · Cited by 361
NICOLL, C. S., MAYER, G. L., & RUSSELL, S. M. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-2-169 · Cited by 353
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).
Patel, Y. C., & Srikant, C. B. (1994) · Endocrinology · doi:10.1210/endo.135.6.7988476 · Cited by 348
Laron Dwarfism and Mutations of the Growth Hormone–Receptor Gene
Amselem, S., Duquesnoy, P., Attree, O., Novelli, G., Bousnina, S., Postel-Vinay, M.-C., & Goossens, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910123211501 · Cited by 316
Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.
Yasuda, K., Rens-Domiano, S., Breder, C. D., Law, S. F., Saper, C. B., Reisine, T., & Bell, G. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88719-7 · Cited by 309
Doi, T., Striker, L. J., Quaife, C. J., Conti, F., Palmiter, R. D., Behringer, R. R., Brinster, R. L., & Striker, G. E. (1988) · PubMed Central · Cited by 299
Yamada, Y. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2136 · Cited by 294
Molecular cloning and functional expression of a brain-specific somatostatin receptor.
Bruno, J. F., Xu, Y., Song, J., & Berelowitz, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11151 · Cited by 294
GOFFIN, V., SHIVERICK, K. T., KELLY, P. A., & MARTIAL, J. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-385 · Cited by 293
Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience
Ahmed, Elsheikh, Stratton, Page, Adams, & Wass (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00760.x · Cited by 291
Negative regulation of the JAK/STAT pathway
Starr, R., & Hilton, D. J. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199901)21:1<47::aid-bies6>3.0.co;2-n · Cited by 287
Bass, S. H., Mulkerrin, M. G., & Wells, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4498 · Cited by 283
Freda, P. U., Wardlaw, S. L., & Post, K. D. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.3.0353 · Cited by 281
ABE, H., MOLITCH, M. E., VAN WYK, J. J., & UNDERWOOD, L. E. (1983) · Endocrinology · doi:10.1210/endo-113-4-1319 · Cited by 281
O'Carroll, A. M., Lolait, S. J., König, M., & Mahan, L. C. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09269-7 · Cited by 274
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors.
Rudling, M., Norstedt, G., Olivecrona, H., Reihnér, E., Gustafsson, J. A., & Angelin, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6983 · Cited by 269
Growth hormone and the adipose conversion of 3T3 cells
Morikawa, M., Nixon, T., & Green, H. (1982) · Cell · doi:10.1016/0092-8674(82)90440-8 · Cited by 256
Acromegaly and gastrointestinal cancer
Ron, E., Gridley, G., Hrubec, Z., Page, W., Arora, S., & Fraumeni, J. F. (1991) · Cancer · doi:10.1002/1097-0142(19911015)68:8<1673::aid-cncr2820680802>3.0.co;2-0 · Cited by 250
Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol
Clark, R., Olson, K., Fuh, G., Marian, M., Mortensen, D., Teshima, G., Chang, S., Chu, H., Mukku, V., Canova-Davis, E., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21969 · Cited by 246
Newman, C. B., Melmed, S., Snyder, P. J., Young, W. F., Boyajy, L. D., Levy, R., Stewart, W. N., Klibanski, A., Molitch, M. E., & Gagel, R. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673422 · Cited by 245
Long-term treatment of acromegaly with bromocriptine.
Wass, J. A., Thorner, M. O., Morris, D. V., Rees, L. H., Mason, A. S., Jones, A. E., & Besser, G. M. (1977) · BMJ · doi:10.1136/bmj.1.6065.875 · Cited by 242
Conventional Supervoltage Irradiation Is an Effective Treatment for Acromegaly
EASTMAN, R. C., GORDEN, P., & ROTH, J. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-931 · Cited by 241
Clinical Manifestations of Acromegaly
Molitch, M. E. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30204-4 · Cited by 239
All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl Cyclase
Patel, Y. C., Greenwood, M. T., Warszynska, A., Panetta, R., & Srikant, C. B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1088 · Cited by 239
BARKAN, A. L., BEITINS, I. Z., & KELCH, R. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-69 · Cited by 239
Long-term Treatment of 189 Acromegalic Patients With the Somatostatin Analog Octreotide
Vance, M. L. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400080073013 · Cited by 237
Distribution of somatostatin receptors in normal and tumor tissue
Reubi, J. C., Kvols, L., Krenning, E., & Lamberts, S. W. J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90217-z · Cited by 234
Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly
Colao, A., Ferone, D., Cappabianca, P., De, M. D. B., Marzullo, P., Monticelli, A., Alfieri, A., Merola, B., Calì, A., de Divitiis, E., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3308 · Cited by 234
Growth Hormone (GH), GH Receptor, and Signal Transduction
Kopchick, J. J., & Andry, J. M. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3068 · Cited by 231
Self-citationTreatment of Acromegaly with Dopamine Agonists
Jaffe, C. A., & Barkan, A. L. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30210-x · Cited by 220
Barrande, G., Pittino-Lungo, M., Coste, J., Ponvert, D., BERTAGNA, X. Y., LUTON, J. P., & Bertherat, J. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3779 · Cited by 216
Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues
McCormick, A., Brady, H., Theill, L. E., & Karin, M. (1990) · Nature · doi:10.1038/345829a0 · Cited by 212
Current Treatment Guidelines for Acromegaly1
Melmed, S., Jackson, I., Kleinberg, D., & Klibanski, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.4995 · Cited by 210
Rational design of receptor-specific variants of human growth hormone.
Cunningham, B. C., & Wells, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3407 · Cited by 208
Identification of a new G-protein-linked receptor for growth hormone secretagogues.
Pong, S. S., Chaung, L. Y., Dean, D. C., Nargund, R. P., Patchett, A. A., & Smith, R. G. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.1.8838145 · Cited by 203
Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure
Sheaves, R., Jenkins, P., Blackburn, P., Huneidi, A. H., Afshar, F., Medbak, S., Grossman, A. B., Besser, G. M., & Wass, J. A. H. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8370847.x · Cited by 199
Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice.
Chen, W. Y., Wight, D. C., Wagner, T. E., & Kopchick, J. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5061 · Cited by 199
Self-citationGovers, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.28 · Cited by 192
Hartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G., & Thorner, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116480 · Cited by 192
Hilding, A., Hall, K., Wivall-Helleryd, I.-L., Sääf, M., Melin, A.-L., & Thorén, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5793 · Cited by 182
Activation of Acute Phase Response Factor (APRF)/Stat3 Transcription Factor by Growth Hormone
Campbell, G. S., Meyer, D. J., Raz, R., Levy, D. E., Schwartz, J., & Carter-Su, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3974 · Cited by 179
Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide1
Caron, P. J., Morange, I., Cogne, M., & Jaquet, P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3714 · Cited by 179
Barkan, A. L., Halasz, I., Dornfeld, K. J., Jaffe, C. A., Friberg, R. D., Chandler, W. F., & Sandler, H. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4249 · Cited by 177
Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon
Gittoes, N. J. L. (1999) · QJM · doi:10.1093/qjmed/92.12.741 · Cited by 176
Sandostatin LAR in Acromegalic Patients: Long Term Treatment
Fløgstad, A. K., Halse, J., Bakke, S. J., Lancranjan, I., Marbach, P., Bruns, C., & Jervell, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3572 · Cited by 176
Physiology of Growth Hormone Secretion and Action
Casanueva, F. F. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30199-3 · Cited by 173
Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent
van Kerkhof, P., Govers, R., Alves dos Santos, C. M., & Strous, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1575 · Cited by 170
Linzer, D. I., & Nathans, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4255 · Cited by 169
Hypopituitarism following radiation therapy of pituitary adenomas
Snyder, P. J., Fowble, B. F., Schatz, N. J., Savino, P. J., & Gennarelli, T. A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90299-8 · Cited by 167
Results of a European Multicentre Study with Sandostatin® LAR® in Acromegalic Patients
Lancranjan, I., Atkinson, A. B., & Sandostatin® LAR® Group# (1999) · Pituitary · doi:10.1023/a:1009980404404 · Cited by 166
Mediation of Growth Hormone-dependent Transcriptional Activation by Mammary Gland Factor/Stat 5
Wood, T. J. J., Sliva, D., Lobie, P. E., Pircher, T. J., Gouilleux, F., Wakao, H., Gustafsson, J., Groner, B., Norstedt, G., & Haldosén, L.-A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9448 · Cited by 166
Glycine 119 of Bovine Growth Hormone is Critical for Growth-Promoting Activity
Chen, W. Y., Wight, D. C., Mehta, B. V., Wagner, T. E., & Kopchick, J. J. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1845 · Cited by 165
Self-citationCharacterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor, K., O'Carroll, A. M., Kong, H., Yasuda, K., Mahan, L. C., Bell, G. I., & Reisine, T. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13184-2 · Cited by 163
CHIHARA, K., MINAMITANI, N., KAJI, H., ARIMURA, A., & FUJITA, T. (1981) · Endocrinology · doi:10.1210/endo-109-6-2279 · Cited by 160
Flyvbjerg, A., Bennett, W. F., Rasch, R., Kopchick, J. J., & Scarlett, J. A. (1999) · Diabetes · doi:10.2337/diabetes.48.2.377 · Cited by 158
Self-citationMolecular cloning of DNA complementary to bovine growth hormone mRNA.
Miller, W. L., MARTIAL, J. A., & Baxter, J. D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43855-6 · Cited by 156
Chen, W. Y., White, M. E., Wagner, T. E., et al. (1991) · Endocrinology · doi:10.1210/endo-129-3-1402 · Cited by 156
Effect of Different Dopaminergic Agents in the Treatment of Acromegaly
Colao, A. A. L., Ferone, D., Marzullo, P., Sarno, A. D., Cerbone, G., Sarnacchiaro, F., Cirillo, S., Merola, B., & Lombardi, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3648 · Cited by 156
Growth hormone-releasing peptide (GHRP)
Bowers, C. Y. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050257 · Cited by 154
Ross, R. J. M., Leung, K. C., Maamra, M., Bennett, W. F., Doyle, N. S., Waters, M. J., & Ho, K. K. Y. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7403 · Cited by 154
Identification of proliferin mRNA and protein in mouse placenta.
Linzer, D. I. H., Lee, S. J., Ogren, L., Talamantes, F. J., & Nathans, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4356 · Cited by 151
Lissett, Peacey, Laing, Tetlow, Davis, J. R., & Shalet, S. M. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00581.x · Cited by 148
Prediction of efficacy of octreotide therapy in patients with acromegaly
Colao, A. A. L., Ferone, D., Lastoria, S., Marzullo, P., Cerbone, G., Sarno, A. D., Longobardi, S., Merola, B., Salvatore, M., & Lombardi, G. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.6.2356 · Cited by 147
Presurgical octreotide treatment in acromegaly
Stevenaert, A., Harris, A. G., Kovács, K., et al. (1992) · Metabolism · doi:10.1016/0026-0495(92)90031-5 · Cited by 147
Chomczyński, P., Downs, T. R., & Frohman, L. A. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-3-236 · Cited by 144
THE HYPOPHYSIS, CARBOHYDRATE METABOLISM AND DIABETES
Houssay, B. A., & BIASOTTI, A. (1931) · Endocrinology · doi:10.1210/endo-15-6-511 · Cited by 143
Berg, M. A., Guevara‐Aguirre, J., Rosenbloom, A. L., Rosenfeld, R. G., & Francke, U. (1992) · Human Mutation · doi:10.1002/humu.1380010105 · Cited by 142
EVIDENCE FOR AUTOREGULATION OF GROWTH HORMONE SECRETION VIA THE CENTRAL NERVOUS SYSTEM
Tannenbaum, G. S. (1980) · Endocrinology · doi:10.1210/endo-107-6-2117 · Cited by 141
The Human Growth Hormone Gene Locus: Structure, Evolution, and Allelic Variations
Heribert Hirt, A., Kimelman, J., Birnbaum, M. J., Chen, E. Y., Seeburg, P. H., Eberhardt, N. L., & Barta, A. (1987) · DNA · doi:10.1089/dna.1987.6.59 · Cited by 138
Mauras, N., O'Brien, K. O., Welch, S., Rini, A., Helgeson, K., Vieira, N. E., & Yergey, A. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6541 · Cited by 136
Benign and Malignant Tumors in Patients With Acromegaly
Barzilay, J. I. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400080113022 · Cited by 135
Nyberg, F., & Burman, P. (2008) · Hormone Research · doi:10.1159/000184753 · Cited by 134
Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase
Frank, S. J., Gilliland, G., Kraft, A. S., & Arnold, C. S. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956946 · Cited by 133
Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System
Liu, J., Yakar, S., & LeRoith, D. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22349.x · Cited by 132
Gebert, C. A., Park, S.-H., & Waxman, D. J. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.4.9904 · Cited by 131
Identification of a new G-protein-linked receptor for growth hormone secretagogues
Ss, P. (1996) · Molecular Endocrinology · doi:10.1210/me.10.1.57 · Cited by 131
Ram, P. A., & Waxman, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004755200 · Cited by 129
Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients
Muratori, M., Arosio, M., Gambino, G., et al. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03348016 · Cited by 129
Diverse growth hormone receptor gene mutations in Laron syndrome.
Berg, M. A., Argente, J., Chernausek, S. D., Gracia, R., Guevara‐Aguirre, J., Hopp, M., Pérez‐Jurado, L. A., Rosenbloom, A. L., Toledo, S. P. A., & Francke, U. (1993) · Europe PMC (PubMed Central) · Cited by 126
GROWTH HORMONE AND THE METABOLISM OF CARBOHYDRATE AND LIPID IN ADIPOSE TISSUE*
GOODMAN, H. M. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb20367.x · Cited by 124
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
Pollak, M., Blouin, M.-J., Zhang, J.-C., & Kopchick, J. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1895 · Cited by 123
Self-citationGuevara‐Aguirre, J., Rosenbloom, A. L., Vasconez, O., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3743 · Cited by 121
Current Treatment Guidelines for Acromegaly
Melmed, S. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2646 · Cited by 120
Life expectancy following surgery for pituitary tumours
Bates, A. S., Bullivant, B., Sheppard, M. C., & Stewart, P. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00650.x · Cited by 106
Hill, D. J., Riley, S. C., Bassett, N. S., & Waters, M. J. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.646 · Cited by 101
Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice
Chen, N. Y., Chen, W. Y., Bellush, L. L., Yang, C., Striker, L. J., Striker, G. E., & Kopchick, J. J. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835300 · Cited by 100
Self-citationGovers, R., van Kerkhof, P., Schwartz, A. L., & Strous, G. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4851 · Cited by 100
Lamberts, S. W. J., Uitterlinden, A. G., SCHUIJFF, P. C., et al. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb02890.x · Cited by 99
Decidual prolactin-related protein. Identification, molecular cloning, and characterization.
Roby, K. F., Deb, S., Gibori, G., Szpirer, C., Levan, G., Kwok, S. C. M., & Soares, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53669-3 · Cited by 94
Hilding, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.2013 · Cited by 94
Wang, X., Darus, C. J., Xu, B. C., et al. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.10.9121492 · Cited by 92
The role of the WSXWS equivalent motif in growth hormone receptor function.
Baumgartner, J. W., Wells, C. A., Chen, C., & Waters, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62017-x · Cited by 91
Wang, Y.-D., & Wood, W. I. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.3.7539888 · Cited by 91
Walker, J. L., Wyk, J. J. V., & Underwood, L. E. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81163-1 · Cited by 89
The Relationship between Serum GH and Serum IGF-I in Acromegaly Is Gender-Specific
Parkinson, C., Ryder, W. D. J., & Trainer, P. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8006 · Cited by 89
Self-citationLussier, B., French, M. B., Moor, B. C., & Kraicer, J. (1991) · Endocrinology · doi:10.1210/endo-128-1-592 · Cited by 87
The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly
Jenkins, D. J. A., O'Brien, I. A. D., Johnson, A., SHAKESPEAR, R. A., Sheppard, M. C., & Stewart, P. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02913.x · Cited by 87
Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization
Harding, P. A., Wang, X., Okada, S., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6708 · Cited by 87
A comparison of lanreotide and octreotide LAR for treatment of acromegaly
Turner, Vadivale, Keenan, & Wass (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00853.x · Cited by 85
Peacey, S. R., Toogood, A. A., Veldhuis, J. D., Thorner, M. O., & Shalet, S. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7154 · Cited by 83
Li, H., Bartold, P. M., Zhang, C. Z., Clarkson, R. W. E., Young, W. G., & Waters, M. J. (1998) · Endocrinology · doi:10.1210/endo.139.9.6211 · Cited by 83
MEDICAL THERAPY FOR ACROMEGALY
Newman, C. B. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70062-1 · Cited by 82
Guevara‐Aguirre, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.629 · Cited by 82
Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels
Biermasz, N. R., Dulken, H. V., & Roelfsema, F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01095.x · Cited by 77
(1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90272-7 · Cited by 76
Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962–1990
Bliss, P., Kerr, G. R., & Gregor, A. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80187-6 · Cited by 74
Xu, B. C., Wang, X., Darus, C. J., & Kopchick, J. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19768 · Cited by 72
Self-citationTrainer, P. J., Drake, W. M., Perry, L. A., Taylor, N., BESSER, G. M., & Monson, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7664 · Cited by 72
Self-citationNeuroendocrine Control of Growth Hormone Secretion
Tannenbaum, G. S. (1991) · Acta Paediatrica · doi:10.1111/j.1651-2227.1991.tb17962.x · Cited by 70
SOME EFFECTS OF PURIFIED PITUITARY GROWTH HORMONE ON CARBOHYDRATE METABOLISM IN THE RAT1
Milman, A. E., & Russell, J. A. (1950) · Endocrinology · doi:10.1210/endo-47-2-114 · Cited by 69
Growth Hormone-induced Signal Transduction Depends on an Intact Ubiquitin System
Strous, G. J., van Kerkhof, P., Govers, R., Rotwein, P. S., & Schwartz, A. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.40 · Cited by 68
Specific binding sites for growth hormone in cultured mouse thymic epithelial cells
Ban, E., Gagnerault, M. C., Jammes, H., Postel-Vinay, M. C., Haour, F., & Dardenne, M. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90147-4 · Cited by 67
Yoshizato, H., Fujikawa, T., Soya, H., Tanaka, M., & Nakashima, K. (1998) · Endocrinology · doi:10.1210/endo.139.5.6009 · Cited by 66
Mauras, N., Martínez, V., Rini, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6772 · Cited by 66
Parkinson, C., Drake, W., Wieringa, G., Yates, A. P., BESSER, G. M., & Trainer, P. J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01460.x · Cited by 62
Self-citationPituitary adenoma radiotherapy–when, who and how?
Plowman (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00854.x · Cited by 61
Is the Laron Mouse an Accurate Model of Laron Syndrome?
Kopchick, J. J., & Laron, Z. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2890 · Cited by 60
Self-citationRapaport, R., Sills, I. N., Green, L., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673403 · Cited by 59
Carter‐Su, C., King, A. P. J., Argetsinger, L. S., Smit, L. S., VanderKuur, J. A., & Campbell, G. S. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.suppl_s65 · Cited by 58
Ferrari, G. C., PARACCHI, A., Romano, C., Gerevini, G., Boghen, M. F., Barreca, A., FORTINI, P., & Dubini, A. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03695.x · Cited by 57
Mauras, N. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1686 · Cited by 57
Holly, J. M. P., Cotterlll, A. M., Jemmott, R. C., Shears, D., Al‐Othman, S., Chard, T., & Wasa, J. A. H. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03766.x · Cited by 56
The effect of a new slow‐release, long‐acting somatostatin analogue, lanreotide, in acromegaly
Al‐Maskari, M., Gebbie, J., & Kendall-Taylor, P. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8270836.x · Cited by 55
Maamra, M., Finidori, J., Laue, S. V., Simon, S., Justice, S., Webster, J., Dower, S., & Ross, R. J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14791 · Cited by 55
Okada, S., Chen, W. Y., Wiehl, P. E., et al. (1992) · Endocrinology · doi:10.1210/endo.130.4.1547740 · Cited by 51
Massa, G., Vanderschueren‐Lodeweyckx, M., & Bouillon, R. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00985.x · Cited by 51
Szabó, M., Butz, M. R., Banerjee, S. A., Chikaraishi, D. M., & Frohman, L. A. (1995) · Endocrinology · doi:10.1210/en.136.9.4044 · Cited by 50
Parini, P., Angelin, B., Lobie, P. E., Norstedt, G., & Rudling, M. J. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649083 · Cited by 49
Effect of Growth Hormone on Cardiac Function
Lombardi, G., Colao, A., Ferone, D., et al. (2009) · Hormone Research · doi:10.1159/000191311 · Cited by 49
Govers, R., van Kerkhof, P., Schwartz, A. L., & Strous, G. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16426 · Cited by 47
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
Drake, W., Parkinson, C., Akker, S., Monson, J., BESSER, G. M., & Trainer, P. J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450451 · Cited by 47
Self-citationWalker, J. L., Crock, P., Behncken, S. N., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4954 · Cited by 46
Vahl, N., Jørgensen, J., Hansen, T., Klausen, I., Jurik, A.-G., Hagen, C., & Christiansen, J. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800618 · Cited by 46
Growth hormone directly affects the function of the different lobes of the rat prostate
Reiter, É., Kecha, O., Hennuy, B., Lardinois, S., Klug, M., Bruyninx, M., Closset, J., & Hennen, G. P. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628369 · Cited by 42
Cellular localization of growth hormone receptors/binding proteins in immune tissues
Hull, K., Thiagarajah, A. S., & Harvey, S. (1996) · Cell and Tissue Research · doi:10.1007/s004410050676 · Cited by 40
The GH Receptor and Signal Transduction
Kelly, P. A., Goujon, L., Sotiropoulos, A., et al. (2008) · Hormone Research · doi:10.1159/000184185 · Cited by 39
Mode, A., Tollet, P., Wells, T., et al. (1996) · Endocrinology · doi:10.1210/endo.137.2.8593788 · Cited by 39
Nolte, W., Rädisch, C., Armstrong, V. W., Hüfner, M., & Mühlen, A. V. Z. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370459 · Cited by 39
Embryonic stem cells express growth hormone receptors: regulation by retinoic acid.
Ohlsson, C., Lövstedt, K., Holmes, P., et al. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243317 · Cited by 36
Walker, J. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2554 · Cited by 33
Wilson, M. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5279 · Cited by 32
O’Halloran, D., Wieringa, G. E., Tsatsoulis, A. A., & Shalet, S. M. (1996) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329603300408 · Cited by 32
HDL‐cholesterol reductions associated with adult growth hormone replacement
Leese, Wallymahmed, VanHeyningen, Tames, Wieringa, & Macfarlane (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00597.x · Cited by 28
Radiotherapy for pituitary tumours
Plowman, P. N. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80434-x · Cited by 17
Growth hormone receptor and regulation of gene expression in fetal lymphoid cells
Chen, H.-T. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00230-x · Cited by 17
Swislocki, N. I. (1968) · Metabolism · doi:10.1016/0026-0495(68)90145-5 · Cited by 15
Wilson, M. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6522 · Cited by 14
Conflicts with the sornatopause
Toogood, A. A., & Shalet, S. M. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80009-9 · Cited by 10
Cited by
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Møller, N., & Jørgensen, J. O. L. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0027 · Cited by 1,039
Metadata
- Authors
- Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2002-10-01
- Volume
- 23
- Issue
- 5
- Pages
- 623-646
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2113464653
- Cited by
- 352
- References
- 197
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.